drugset / Trial / NCT03690089

Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom

NCT03690089

Phase 2 Active not recruiting 289 enrolled Belfast Health and Social Care Trust
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Short-sightedness, also called myopia, makes objects in the distance, such as the television, look blurred. This is caused by the eye growing too long, something that usually happens while children are also getting taller. People with myopia can see better with glasses or contact lenses, but this doesn't stop their eyes continuing to become more short-sighted. The CHAMP UK study is investigating a type of eye drop called atropine that might help to stop myopia getting worse as children get older.

Timeline

Start
2019-04-03
Primary completion
2024-02-29
Completion
2027-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.01 % Topical

Indications